CORONARY THROMBOLYSIS - PHARMACOLOGICAL CONSIDERATIONS WITH EMPHASIS ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA)

被引：23

作者：

FOX, KAA ^{[1
]}

BERGMANN, SR ^{[1
]}

SOBEL, BE ^{[1
]}

机构：

[1] WASHINGTON UNIV,SCH MED,DIV CARDIOVASC,ST LOUIS,MO 63110

来源：

关键词：

D O I：

10.1016/0006-2952(84)90536-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1831 / 1838

页数：8

共 67 条

[1] ASTRUP T, 1966, FED PROC, V25, P42
[2] SUPRAOPTIC NEUROSECRETORY CELLS - ADRENERGIC AND CHOLINERGIC SENSITIVITY
BARKER, JL
[J]. SCIENCE, 1971, 171 (3967) : 208 - +
[3] BIOCHEMICAL-COMPARISON OF INTERMITTENT STREPTOKINASE AND INTERMITTENT STREPTOKINASE PLASMINOGEN THERAPY
BARLOW, GH
KAKKAR, VV
BENTLEY, PG
CHAN, PS
JONES, NAG
MISTRY, FD
[J]. THROMBOSIS RESEARCH, 1979, 15 (1-2) : 135 - 142
[4] TEMPORAL DEPENDENCE OF BENEFICIAL-EFFECTS OF CORONARY THROMBOLYSIS CHARACTERIZED BY POSITRON TOMOGRAPHY
BERGMANN, SR
LERCH, RA
FOX, KAA
LUDBROOK, PA
WELCH, MJ
TERPOGOSSIAN, MM
SOBEL, BE
[J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (04) : 573 - 581
[5] BERGMANN SR, 1983, SCIENCE, V220, P1181
[6] BOWIE EJW, 1982, THROMBOLYSIS, P7
[7] STREPTOKINASE - REVIEW OF ITS CLINICAL PHARMACOLOGY, MECHANISM OF ACTION AND THERAPEUTIC USES
BROGDEN, RN
SPEIGHT, TM
AVERY, GS
[J]. DRUGS, 1973, 5 (5-6) : 357 - 445
[8] SHORT-TERM ENHANCEMENT OF PLASMINOGEN ACTIVATOR INVIVO BY DRUGS
CASH, JD
[J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 34 (03): : 648 - 651
[9] CASH JD, 1975, PROGR CHEM FIBRINOLY, V1, P97
[10] CASH JD, 1978, PROGR CHEM FIBRINOLY, V3, P65